Drug Manufacturers in the News – TEVA, AMRN, FRX, ENDP
Houston, TX – January 23, 2013 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: TEVA, AMRN, FRX, ENDP
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) revealed that, on Thursday, February 7, 2013 at 7:00 a.m. EST, it will release the financial results of its fourth quarter and full year 2012.
At 8:00 a.m. EST on the same day, the company will host a conference call and live webcast to discuss its results for the fourth quarter and full year 2012 and after this discussion a question & answer session has been scheduled.
Teva Pharmaceutical Industries percentage change surged 0.53% to close at $37.91 with the total traded volume of 4.01 million shares, as compared to average volume of 5.86 million shares.
Get A Free Report And Detailed Analysis On TEVA CLICK HERE To Read
TEVA’s total market capitalization is $32.91 billion along with 868.00 million shares outstanding. Its beta value stands at 0.35 points and its earning per share remained $2.44. Company’s lowest price during last trade was $37.53 while its highest price remained 37.92 for the day.
Amarin Corporation plc (ADR)(NASDAQ:AMRN) reported a drop of -2.24%. After opening at the price of $8.63 its closing price for the day was $8.28.
Amarin Company’s earning per share is $-1.09 while its beta value stands at 1.46 times. Company’s current market capitalization stands at $1.24 billion along with 149.77 million shares.
Is AMRN A Solid Investment At These Levels? Find Out Exactly Where AMRN Is Headed With This TREND ANALYSIS REPORT
AMRN’s total trading volume for the day was 4.86 million shares, versus its average volume of 5.45 million shares. If we look at the previous 5 day’s performance of the stock, it remained decreasing with the loss of -3.94%. In its last one month’s trade it surged 4.02%.
Forest Laboratories, Inc. (NYSE:FRX) percentage change increased 0.52% to close at $36.96 with the total traded volume of 1.84million shares, as compared to average volume of 1.70 shares.
Forest Laboratories, Inc. reported that its Canadian subsidiary, Forest Laboratories Canada Inc., has received a Compliance Notice from Health Canada for the tablets BYSTOLIC® (nebivolol). This tablet is used for the treatment of hypertension.
How Should Investors React To FRX Now? Find Out In This TREND ANALYSIS REPORT
FRX’s shares were trading within the range of $36.60-$37.04 while its opening price was $36.80. Its market capitalization is $9.83 billion and EPS was $0.42. If we look at its previous three months trade, it gained 6.76%, while in the last 5 day’s it remained down -1.68%.
Endo Health Solutions Inc (NASDAQ:ENDP) reported the increase of 2.95% and closed at $27.61 with the total traded volume of 2.17 million shares. The stock’s opening price was $26.76.
The 52-week price range of the stock remained $25.00 – $39.29, while during last trade its minimum price was $26.55 and it gained its highest price of $27.65.
How Should Investors Trade ENDP Now? Don’t Trade ENDP Until You Read This TREND ANALYSIS REPORT
The company has a total of 114.10 million outstanding shares and its total market capitalization is $3.15 billion. The Company’s last 5 days shows an uptrend of 5.16%.
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.